Search Results
Nov 13, 2025, 18:08 ET LODD procède au premier vol de Hili, le premier drone hybride de fret lourd des Émirats arabes unis (EAU), conçu, construit et testé à Abou Dabi
un leader mondial de confiance dans le secteur des opérations par drone. Skyports, qui mène des opérations de livraison par drone pour Royal Mail, le NHS et des entreprises d'énergie éolienne en mer de premier plan telles qu'Equinor et RWE, voit dans Hili un grand potentiel pour l'expansion de ses capacités
More news about: Abu Dhabi Autonomous Week
Nov 13, 2025, 18:00 ET LODD completa el primer vuelo de Hili, el primer UAV de carga pesada híbrido de los EAU
acuerdo con Skyports Drone Services, líder mundial en operaciones con drones. Skyports, que gestiona operaciones de entrega con drones para Royal Mail, el NHS y empresas líderes en energía marina como Equinor y RWE, ve un gran potencial en Hili para ampliar sus capacidades de carga con drones de largo alcance
More news about: Abu Dhabi Autonomous Week
Nov 13, 2025, 10:19 ET LODD Completes First Flight of Hili - The UAE's First Hybrid Heavy Cargo UAV, Designed, Built and Tested in Abu Dhabi
signed an agreement with Skyports Drone Services, a trusted global leader in drone operations. Running drone delivery operations for Royal Mail, the NHS and offshore energy leaders such as Equinor and RWE, Skyports sees great potential in Hili for expanding its heavy-lift, long range cargo drone capabilities.
More news about: Abu Dhabi Autonomous Week
Nov 13, 2025, 10:06 ET LODD Completes First Flight of Hili - The UAE's First Hybrid Heavy Cargo UAV, Designed, Built and Tested in Abu Dhabi
signed an agreement with Skyports Drone Services, a trusted global leader in drone operations. Running drone delivery operations for Royal Mail, the NHS and offshore energy leaders such as Equinor and RWE, Skyports sees great potential in Hili for expanding its heavy-lift, long range cargo drone capabilities.
More news about: Abu Dhabi Autonomous Week
Nov 13, 2025, 07:00 ET Acosta Europe Announces New President, Nicole Brittain
a Certified Mediator (ACAS), and studied at Oxford Saïd Business School, University of Oxford. She also serves as Chair of the Board of Trustees for NHS Shropshire. For more information about Acosta Europe please visit
More news about: Acosta Group
Nov 12, 2025, 07:01 ET Diversis Capital Announces Strategic Investments and Combination of Genesis Automation Healthcare, Kermit, and Meperia to create the First End-to-End Healthcare Supply Chain and Inventory Management Platform
patients. Current major customers of the three combined companies agree: Simon Walsh, Chief Procurement Officer at Manchester University NHS Trust, highlighted the impact of Genesis's platform: "Our partnership with Genesis not only gives us all the benefits in terms of product tracking
More news about: Diversis
Nov 10, 2025, 10:15 ET AHA 2025: New study from Genomics shows polygenic risk scores improve the accuracy of cardiovascular disease risk prediction
the United Kingdom's National Health Service (NHS), demonstrated that integrating genetic data into cardiovascular risk assessments fitted smoothly into clinical care pathways and changed patient management. The recently released 10-year plan for the NHS committed to rolling out prevention based on PRS
More news about: Genomics
Nov 05, 2025, 10:12 ET Axiom accelerates North American expansion plans with acquisition of IS Partners
over 1,300 specialists supports leading organizations including Bentley, Walmart, Shell Energy and Sony, as well as the National Health Service (NHS) England and thousands of small- to medium-sized enterprises across all sectors. About Axiom GRCAxiom
More news about: Axiom GRC
Nov 04, 2025, 10:30 ET Bariatric Beds Market to Reach $583.8 million, Globally, by 2034 at 5.3% CAGR: Allied Market Research
and increasing public health initiatives targeting obesity. Countries such as the UK, Germany, and France are major contributors. In the UK alone, the NHS reported that over 1 million hospital admissions in 2022 were linked to obesity-related conditions, highlighting the need for specialized equipment such
More news about: Allied Market Research
Nov 04, 2025, 06:45 ET Subtle Medical Enters UK Market to Drive Faster, Higher Quality MRI with SubtleHD™
NHS GIRFT
More news about: Subtle Medical, Inc.
Nov 03, 2025, 08:29 ET Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes
The study, conducted in collaboration with the UK's National Health Service ("NHS"), has achieved full enrolment ahead of schedule, reaching its target of 160 participants. It was randomised in a 3:1 ratio between symptomatic and non-symptomatic
More news about: Virax BioLabs Group Limited
Nov 01, 2025, 03:00 ET Two Billion Live with Vision Impairment -- Can AI Help Prevent Sight Loss?
Keane details how demand for eye care now outpaces capacity: in the UK, ophthalmology is the busiest medical specialty, accounting for nearly 10% of all NHS appointments—about 10 million annually—up by more than a third in five years. He highlights age-related macular degeneration (AMD) as a leading cause
More news about: Planet Classroom Network
Oct 31, 2025, 16:30 ET NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
YORK, Oct. 31, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on November
More news about: Neuberger Berman
Oct 31, 2025, 13:06 ET Cybersecurity, Enterprise Architecture, and IT Strategy Take Center Stage as Info-Tech LIVE 2025 in Montreal Expands Speaker Lineup
Architect, helping members strengthen their data and architecture capabilities. He has held senior leadership roles with Siemens Consulting, the UK NHS, BBC, UK Parliament, and Loblaw Companies Limited, and spent a decade teaching enterprise architecture at the University of Toronto. Neill's expertise
More news about: Info-Tech Research Group
Oct 28, 2025, 09:03 ET ALTIUS AND SYD LIFE AI ANNOUNCE $1BN PARTNERSHIP TO TRANSFORM U.S. HEALTHCARE AND WORKFORCE THROUGH PREVENTIVE ARTIFICIAL INTELLIGENCE
Exclusive partnership brings to the U.S. personalized AI preventive care platform, validated in clinical trials by the UK's NHS, to save employers billions of dollars and improve millions of lives
More news about: Syd Life AI
Oct 28, 2025, 09:00 ET ALTIUS AND SYD LIFE AI ANNOUNCE $1BN PARTNERSHIP TO TRANSFORM U.S. HEALTHCARE AND WORKFORCE THROUGH PREVENTIVE ARTIFICIAL INTELLIGENCE
Exclusive partnership brings to the U.S. personalized AI preventive care platform, validated in clinical trials by the UK's NHS, to save employers billions of dollars and improve millions of lives
More news about: Syd Life AI
Oct 27, 2025, 09:00 ET Queen Square Imaging Centre: New technique could improve outcomes for essential tremor patients
: World-leading neuroimaging facility and diagnostic imaging facility, serving NHS and private patients. The UK's only independent centre offering MRgFUS, Deep Brain Stimulation (DBS), Radiofrequency Ablation
More news about: Queen Square Imaging Centre
Oct 27, 2025, 09:00 ET Queen Square Imaging Centre: New technique could improve outcomes for essential tremor patients
: World-leading neuroimaging facility and diagnostic imaging facility, serving NHS and private patients. The UK's only independent centre offering MRgFUS, Deep Brain Stimulation (DBS), Radiofrequency Ablation
More news about: Queen Square Imaging Centre
Oct 27, 2025, 09:00 ET Queen Square Imaging Centre : une nouvelle technique pourrait améliorer les résultats pour les patients atteints de tremblement essentiel
Centre de neuro-imagerie et d'imagerie diagnostique de premier plan au niveau mondial, au service des patients du NHS et du secteur privé. Le seul centre indépendant du Royaume-Uni à proposer au même endroit la MRgFUS, la stimulation cérébrale
More news about: Queen Square Imaging Centre
Oct 23, 2025, 09:00 ET Contaminated water threatens food chain as pollution incidents surge, warns Hydrachem
disinfection and sterilisation. Operating in over 60 countries, the company partners with NGOs, governments and leading healthcare institutions, including the NHS, to combat waterborne diseases, maintain hygienic environments and produce over 10 billion litres of safe drinking water each year.
More news about: Hydrachem
Oct 20, 2025, 06:00 ET GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC)
and was responsible for data collection, analysis and interpretation. The study was funded by GRAIL with support from National Health Service (NHS) England, NHS Wales, the National Institute for Health and Care Research (NIHR) and NIHR Oxford Biomedical Research Centre.
More news about: GRAIL, Inc.
Oct 18, 2025, 05:03 ET GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings
application, along with data from the prevalent screening round of the NHS-Galleri trial. In addition, GRAIL will submit to the FDA a bridging analysis to compare performance of the version of Galleri used in the PATHFINDER 2 study and the NHS-Galleri trial to the updated version that GRAIL plans to submit
More news about: GRAIL, Inc.
Oct 17, 2025, 10:37 ET Wobble Genomics Presents Latest Data at ESMO: establishing the robustness of an enhanced liquid biopsy platform for sensitive detection of low-abundance RNA
advisors in genomics, diagnostics and oncology. Wobble Genomics is currently conducting clinical studies in partnership with the National Health Service (NHS) in the UK. For more information about Wobble Genomics, please visit
More news about: Wobble Genomics
Oct 17, 2025, 08:00 ET Lilly's Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment
the adjuvant setting," said Stephen Johnston, M.D., Ph.D., Professor of Breast Cancer Medicine and Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust (London, U.K.) and lead investigator for monarchE. "These results represent an important step forward in the treatment of high-risk
More news about: Eli Lilly and Company
Oct 14, 2025, 07:00 ET Caristo Chosen by Leading Pharma Company as Worldwide Imaging Core Lab to Measure Coronary Plaque and Inflammation
shed important light on a drug's mode of action," said Dr Cheerag Shirodaria, Honorary Consultant Cardiologist at Oxford University Hospitals NHS Foundation Trust. "The information provided by the REMBRANDT trial will provide clinicians with valuable information on the direct effects of obicetrapib
More news about: Caristo Diagnostics